The 2020 Endpoint Adjudication Forum is an advanced conference on endpoint adjudication. Over the course of this beyond-the-basics forum, attendees will 1) analyze strategies to craft a charter; 2) discuss principles for instituting a Clinical Endpoint Committee (CEC); 3) scrutinize procedures for capturing, managing and monitoring data; and 4) look at guidance documents for adjudication.

Through networking, case studies and panel discussions, professionals from biotech, pharmaceutical and medical device companies will return to work with the necessary tools and acumen to enhance and streamline endpoint adjudication. This conference will feature an embedded master class on the first morning of the conference, which will clarify the fundamentals of endpoint adjudication.

With two days of educational content and ample networking time, the 2020 Endpoint Adjudication Forum is a must-attend event for professionals aiming to adapt and otherwise improve upon endpoint adjudication best practices.

Top Five Reasons to Attend

• Learn to balance the FDA’s regulatory requests and demands with the practicality of performing a CEC for a trial
• Establish guidance documents for adjudication
• Enhance trial integrity and prepare data for adjudication submission and approval
• Analyze inconsistencies in adjudication data sets while learning to construct an effective database
• Comply with regulations through standard submissions

Who Should Attend

This conference is designed for professionals in biotech, pharmaceutical and medical device companies with responsibilities in the following areas:

• Medical/Clinical Safety
• Medical/Scientific Affairs
• Clinical Operations
• Event Adjudication
• Biostatistics
• Pharmacovigilance
• Protocol Management
• Clinical Monitoring
• Data Management
• Electronic Data Capture
• Clinical Development
• Project/Trial Management
• Regulatory
• Study Design
• Informatics
• Safety Operations
• Medical Products Safety